State governments are free to procure Covid-19 vaccine doses from vaccine manufacturers
NEW DELHI: There have been some media reports suggesting that Serum Institute of India (SII) has contracted all its production...
NHM Team
Green corridors helping in fast movement of oxygen express
NEW DELHI: Indian Railway is running Oxygen Express in response to its fight against Covid-19. First Oxygen Express with Liquid...
Narendra Modi holds a high level meeting on oxygen supply and availability
NEW DELHI: Prime Minister (PM) Narendra Modi chaired a high-level meeting to review the oxygen supply across the country and...
Covid-19: India adds 2,59,170 new cases in single day, record 1,761 fatalities
NEW DELHI: India's total tally of COVID-19 cases climbed to 1,53,21,089 with 2,59,170 new coronavirus infections being reported in a...
11 states, Union Territories administered first dose of Covid-19 vaccine to over 90% of health workers
NEW DELHI: The cumulative number of Covid-19 vaccine doses administered in the country crossed 13 crore on Wednesday, with 11...
States to get Covishield vaccine at Rs 400, pvt hospitals at Rs 600 a dose
NEW DELHI: Covishield will be sold at Rs 400 per dose to the state government and Rs 600 to private...
New Covid-19 vaccine may provide protection against future strains: Scientists
NEW DELHI: A new experimental COVID-19 vaccine has shown promising results in early animal testing, according to researchers who say...
Private Covid-19 vaccination centres to procure directly from makers from May 1
NEW DELHI: From May 1, the present system of private COVID-19 vaccination centres receiving doses from the government and charging...
Covaxin neutralises double mutant strain: ICMR
NEW DELHI: Indigenously developed COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain...
Johnson & Johnson seeks permission for phase-3 trial of its single-shot Covid-19 vaccine in India, import license
NEW DELHI: Multinational pharma giant Johnson & Johnson has applied to India's drug regulator seeking permission to conduct phase-3 clinical...
